⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL285987 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL9127358 | 0.97 | — | — | |
| SCHEMBL25487800 | 0.82 | — | — | |
| SCHEMBL830552 | 0.78 | — | — | |
| SCHEMBL29011216 | 0.76 | — | — | |
| SCHEMBL9529554 | 0.75 | — | — | |
| SCHEMBL18140092 | 0.71 | TDP1 (0.36) | — | |
| SCHEMBL17633086 | 0.71 | HPGD (0.36) | — | |
| SCHEMBL15998905 | 0.71 | MAPT (0.69) | — | |
| SCHEMBL9127347 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119074944-B | Nanopharmaceutical delivery system for targeting central nerve through nose and brain, preparation method and application thereof | 太一生命科技(宁波)有限公司 | 2025-06-24 | — | — | CN | claimed |
| CN-119074944-A | Nanopharmaceutical delivery system for targeting central nerve through nose and brain, preparation method and application thereof | 太一生命科技(宁波)有限公司 | 2024-12-06 | — | — | CN | claimed |
| CN-117752810-A | CD16 a-based targeted lipid nanoparticle and composition, pharmaceutical preparation and application thereof | 苏州科锐迈德生物医药科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-114316096-A | Functionalized polyolefin elastomer and preparation method thereof | 常州汉韦聚合物有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-10385013-B2 | Micro/nano materials, products obtained by covalently modifying surface of micro/nano materials with hydrophilic materials, and method for making same | CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) | 2019-08-20 | — | — | US | claimed |
| EP-3470443-A1 | MICRO/NANOMATERIAL, PRODUCT THEREOF WITH SURFACE COVALENTLY MODIFIED WITH HYDROPHILIC MATERIAL, AND MANUFACTURING METHOD | Chongqing Bolanying (BLY) Biotechnology Co., Ltd., China (CN) | 2019-04-17 | — | — | EP | claimed |
| US-20190077746-A1 | MICRO/NANO MATERIALS, PRODUCTS OBTAINED BY COVALENTLY MODIFYING SURFACE OF MICRO/NANO MATERIALS WITH HYDROPHILIC MATERIALS, AND METHOD FOR MAKING SAME | CHONGQING BOLANYING (BLY) BIOTECHNOLOGY CO., LTD. (CN) | 2019-03-14 | — | — | US | claimed |
| CN-119074944-B | Nanopharmaceutical delivery system for targeting central nerve through nose and brain, preparation method and application thereof | 太一生命科技(宁波)有限公司 | 2025-06-24 | — | — | CN | disclosed |
| CN-119074944-A | Nanopharmaceutical delivery system for targeting central nerve through nose and brain, preparation method and application thereof | 太一生命科技(宁波)有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-117752810-A | CD16 a-based targeted lipid nanoparticle and composition, pharmaceutical preparation and application thereof | 苏州科锐迈德生物医药科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117653719-A | Tumor in-situ vaccine and preparation method and application thereof | 中国药科大学 | 2024-03-08 | — | — | CN | disclosed |
| US-20230374081-A1 | PREVENTION, TREATMENT AND DIAGNOSIS OF P.GINGIVALIS INFECTION | ORAL HEALTH AUSTRALIA PTY LTD (AU) | 2023-11-23 | — | — | US | disclosed |
| US-11572391-B2 | Antibodies for prevention, treatment and diagnosis of P. gingivalis infection | ORAL HEALTH AUSTRALIA PTY LTD (AU) | 2023-02-07 | — | — | US | disclosed |
| EP-1017714-A1 | SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) | THE UNIVERSITY OF MELBOURNE (AU) | 2000-07-12 | — | — | EP | disclosed |
| WO-1998049192-A1 | SYNTHETIC PEPTIDE CONSTRUCTS FOR THE DIAGNOSIS AND TREATMENT OF PERIODONTITIS ASSOCIATED WITH $i(PORPHYROMONAS GINGIVALIS) | THE UNIVERSITY OF MELBOURNE (AU) | 1998-11-05 | — | — | WO | disclosed |
| EP-0495265-B1 | Acid-labile linker molecules | AKZO NOBEL NV (NL) | 1994-08-03 | — | — | EP | disclosed |
| US-5306809-A | Cancer immune therapy | AKZO N.V. (NL) | 1994-04-26 | — | — | US | disclosed |
| EP-0495265-A1 | Acid-labile linker molecules | Akzo Nobel N.V. (NL) | 1992-07-22 | — | — | EP | disclosed |
| EP-0339695-A2 | A process for preparing an antigenic or immunogenic conjugate as well as the use of such conjugates | STICHTING VOOR DE TECHNISCHE WETENSCHAPPEN (NL) | 1989-11-02 | — | — | EP | disclosed |
| US-4613587-A | 2-MERCAPTOACETYL-PHENYLALANINE-LEUCINE AS ENZYME INHIBITOR, GENTAMICIN ANTIBIOTIC | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1986-09-23 | — | — | US | disclosed |